DCF — ST. JOSEPH MEDICAL CENTER
Enterprise Value: $91.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$91.3M
Enterprise Value
$21.3M
PV of Cash Flows
$70.0M
PV of Terminal Value
$112.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $224.1M | $14.4M | 6.0% | $2.7M | $2.5M |
| Year 2 | $230.9M | $17.1M | 7.0% | $4.5M | $3.7M |
| Year 3 | $237.8M | $20.0M | 8.0% | $6.4M | $4.8M |
| Year 4 | $244.9M | $21.9M | 9.0% | $7.6M | $5.2M |
| Year 5 | $252.3M | $23.1M | 9.0% | $8.3M | $5.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $91.3M. Terminal value accounts for 77% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$217.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.059221796662437945
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5